255 related articles for article (PubMed ID: 27688818)
1. The emerging role of lysine methyltransferase SETD8 in human diseases.
Milite C; Feoli A; Viviano M; Rescigno D; Cianciulli A; Balzano AL; Mai A; Castellano S; Sbardella G
Clin Epigenetics; 2016; 8():102. PubMed ID: 27688818
[TBL] [Abstract][Full Text] [Related]
2. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of SETD8 inhibitors.
Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J
Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Ma A; Yu W; Li F; Bleich RM; Herold JM; Butler KV; Norris JL; Korboukh V; Tripathy A; Janzen WP; Arrowsmith CH; Frye SV; Vedadi M; Brown PJ; Jin J
J Med Chem; 2014 Aug; 57(15):6822-33. PubMed ID: 25032507
[TBL] [Abstract][Full Text] [Related]
5. Roles for the methyltransferase SETD8 in DNA damage repair.
Xu L; Zhang L; Sun J; Hu X; Kalvakolanu DV; Ren H; Guo B
Clin Epigenetics; 2022 Mar; 14(1):34. PubMed ID: 35246238
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitors of SETD8 with cellular activity.
Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
[TBL] [Abstract][Full Text] [Related]
7. USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.
Hernández-Reyes Y; Paz-Cabrera MC; Freire R; Smits VAJ
Cells; 2022 Aug; 11(16):. PubMed ID: 36010569
[TBL] [Abstract][Full Text] [Related]
8. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8.
Shi L; Huang L; Long H; Song A; Zhou Z
FASEB J; 2022 Jun; 36(6):e22338. PubMed ID: 35532550
[TBL] [Abstract][Full Text] [Related]
10. Histone lysine methyltransferase Pr-set7/SETD8 promotes neural stem cell reactivation.
Huang J; Gujar MR; Deng Q; Y Chia S; Li S; Tan P; Sung WK; Wang H
EMBO Rep; 2021 Apr; 22(4):e50994. PubMed ID: 33565211
[TBL] [Abstract][Full Text] [Related]
11. [The biological functions of lysine methyltransferase PR-SET7].
Liang XQ; Du YP; Wang DL; Yang Y
Yi Chuan; 2013 Mar; 35(3):241-54. PubMed ID: 23575530
[TBL] [Abstract][Full Text] [Related]
12. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription.
Beck DB; Oda H; Shen SS; Reinberg D
Genes Dev; 2012 Feb; 26(4):325-37. PubMed ID: 22345514
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.
Driskell I; Oda H; Blanco S; Nascimento E; Humphreys P; Frye M
EMBO J; 2012 Feb; 31(3):616-29. PubMed ID: 22117221
[TBL] [Abstract][Full Text] [Related]
14. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Herviou L; Ovejero S; Izard F; Karmous-Gadacha O; Gourzones C; Bellanger C; De Smedt E; Ma A; Vincent L; Cartron G; Jin J; De Bruyne E; Grimaud C; Julien E; Moreaux J
Clin Epigenetics; 2021 Sep; 13(1):174. PubMed ID: 34530900
[TBL] [Abstract][Full Text] [Related]
15. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
[TBL] [Abstract][Full Text] [Related]
16. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
Kukita A; Sone K; Kaneko S; Kawakami E; Oki S; Kojima M; Wada M; Toyohara Y; Takahashi Y; Inoue F; Tanimoto S; Taguchi A; Fukuda T; Miyamoto Y; Tanikawa M; Mori-Uchino M; Tsuruga T; Iriyama T; Matsumoto Y; Nagasaka K; Wada-Hiraike O; Oda K; Hamamoto R; Osuga Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358786
[TBL] [Abstract][Full Text] [Related]
17. Proteome identification of proteins interacting with histone methyltransferase SET8.
Qin Y; Ouyang H; Liu J; Xie Y
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):303-8. PubMed ID: 23419719
[TBL] [Abstract][Full Text] [Related]
18. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.
Wu S; Rice JC
Cell Cycle; 2011 Jan; 10(1):68-72. PubMed ID: 21200139
[TBL] [Abstract][Full Text] [Related]
19. Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication.
Huen MS; Sy SM; van Deursen JM; Chen J
J Biol Chem; 2008 Apr; 283(17):11073-7. PubMed ID: 18319261
[TBL] [Abstract][Full Text] [Related]
20. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells.
Tardat M; Brustel J; Kirsh O; Lefevbre C; Callanan M; Sardet C; Julien E
Nat Cell Biol; 2010 Nov; 12(11):1086-93. PubMed ID: 20953199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]